| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pseudomonas Infections | 45 | 2014 | 623 | 4.570 |
Why?
|
| Pseudomonas aeruginosa | 54 | 2014 | 1276 | 4.020 |
Why?
|
| Anesthesiology | 12 | 2023 | 1137 | 2.780 |
Why?
|
| Pneumonia, Ventilator-Associated | 15 | 2014 | 278 | 2.300 |
Why?
|
| Pneumonia, Bacterial | 11 | 2011 | 320 | 1.690 |
Why?
|
| Bacterial Toxins | 22 | 2014 | 922 | 1.570 |
Why?
|
| Bronchoalveolar Lavage Fluid | 23 | 2011 | 761 | 1.470 |
Why?
|
| Intensive Care Units | 10 | 2022 | 3800 | 1.440 |
Why?
|
| Diabetic Ketoacidosis | 2 | 2023 | 257 | 1.370 |
Why?
|
| Perioperative Care | 8 | 2023 | 1045 | 1.220 |
Why?
|
| Pulmonary Alveoli | 19 | 2008 | 665 | 0.920 |
Why?
|
| Anesthesia | 7 | 2023 | 1596 | 0.910 |
Why?
|
| Antigens, Bacterial | 12 | 2010 | 1150 | 0.840 |
Why?
|
| Laryngoscopes | 2 | 2017 | 147 | 0.820 |
Why?
|
| Respiration, Artificial | 12 | 2020 | 2725 | 0.780 |
Why?
|
| Acidosis | 1 | 2023 | 271 | 0.750 |
Why?
|
| Clinical Alarms | 1 | 2021 | 61 | 0.720 |
Why?
|
| Lung | 39 | 2020 | 10099 | 0.700 |
Why?
|
| Respiratory Tract Infections | 5 | 2012 | 1014 | 0.690 |
Why?
|
| Pore Forming Cytotoxic Proteins | 11 | 2010 | 130 | 0.680 |
Why?
|
| Critical Care | 6 | 2021 | 2716 | 0.660 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 3 | 2011 | 279 | 0.640 |
Why?
|
| Ventilator-Induced Lung Injury | 2 | 2010 | 135 | 0.630 |
Why?
|
| Cataract Extraction | 1 | 2023 | 465 | 0.630 |
Why?
|
| Remote Sensing Technology | 1 | 2019 | 93 | 0.610 |
Why?
|
| Virulence | 13 | 2011 | 1298 | 0.610 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2021 | 354 | 0.600 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2021 | 326 | 0.600 |
Why?
|
| Intubation, Intratracheal | 8 | 2017 | 1359 | 0.590 |
Why?
|
| Anti-Bacterial Agents | 13 | 2020 | 7478 | 0.590 |
Why?
|
| Monitoring, Physiologic | 2 | 2022 | 1798 | 0.560 |
Why?
|
| Cataract | 1 | 2023 | 837 | 0.550 |
Why?
|
| Lung Diseases | 12 | 2008 | 1944 | 0.540 |
Why?
|
| Pulmonary Edema | 16 | 2008 | 409 | 0.480 |
Why?
|
| Respiratory Mucosa | 2 | 2008 | 439 | 0.470 |
Why?
|
| Anesthesia Department, Hospital | 1 | 2014 | 69 | 0.460 |
Why?
|
| Drug Resistance, Bacterial | 6 | 2020 | 1063 | 0.420 |
Why?
|
| Bacterial Proteins | 14 | 2014 | 3840 | 0.400 |
Why?
|
| Antibodies, Bacterial | 8 | 2010 | 1478 | 0.400 |
Why?
|
| Medical Informatics | 1 | 2019 | 742 | 0.400 |
Why?
|
| Pleural Effusion | 8 | 1993 | 345 | 0.390 |
Why?
|
| Trachea | 3 | 2008 | 1095 | 0.390 |
Why?
|
| Pleura | 15 | 1994 | 248 | 0.380 |
Why?
|
| Pneumonia | 5 | 2010 | 2164 | 0.380 |
Why?
|
| Laryngoscopy | 1 | 2017 | 714 | 0.380 |
Why?
|
| Bronchi | 6 | 2010 | 850 | 0.380 |
Why?
|
| Glycolipids | 1 | 2012 | 205 | 0.370 |
Why?
|
| Cross Infection | 3 | 2011 | 1425 | 0.370 |
Why?
|
| Azithromycin | 1 | 2012 | 201 | 0.360 |
Why?
|
| Telemedicine | 2 | 2021 | 3110 | 0.360 |
Why?
|
| Thrombocytopenia | 1 | 2018 | 1181 | 0.350 |
Why?
|
| Bacteriological Techniques | 3 | 2012 | 277 | 0.350 |
Why?
|
| Acute Lung Injury | 1 | 2014 | 378 | 0.350 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2022 | 3683 | 0.340 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 3 | 2011 | 704 | 0.340 |
Why?
|
| Inpatients | 1 | 2021 | 2569 | 0.340 |
Why?
|
| Career Choice | 1 | 2016 | 769 | 0.330 |
Why?
|
| Macrophages, Alveolar | 8 | 2008 | 415 | 0.330 |
Why?
|
| Francisella tularensis | 1 | 2010 | 60 | 0.330 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2008 | 55 | 0.320 |
Why?
|
| Immunoglobulin Fab Fragments | 4 | 2008 | 446 | 0.310 |
Why?
|
| Bacterial Adhesion | 3 | 2003 | 305 | 0.310 |
Why?
|
| Humans | 116 | 2023 | 768970 | 0.300 |
Why?
|
| Bronchoscopes | 1 | 2008 | 64 | 0.300 |
Why?
|
| Metagenome | 1 | 2012 | 465 | 0.300 |
Why?
|
| Schools, Medical | 1 | 2014 | 883 | 0.300 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2011 | 591 | 0.290 |
Why?
|
| ADP Ribose Transferases | 7 | 2011 | 90 | 0.290 |
Why?
|
| Software | 1 | 2021 | 4479 | 0.280 |
Why?
|
| Shock, Septic | 7 | 2002 | 774 | 0.280 |
Why?
|
| Phagocytes | 1 | 2008 | 294 | 0.270 |
Why?
|
| Colony Count, Microbial | 5 | 2008 | 328 | 0.270 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2008 | 133 | 0.270 |
Why?
|
| Rabbits | 13 | 2008 | 4774 | 0.270 |
Why?
|
| Matrix Metalloproteinases | 1 | 2009 | 393 | 0.270 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2014 | 954 | 0.260 |
Why?
|
| Ventilators, Mechanical | 1 | 2008 | 292 | 0.260 |
Why?
|
| Sheep | 18 | 2006 | 1451 | 0.260 |
Why?
|
| Awards and Prizes | 1 | 2010 | 365 | 0.260 |
Why?
|
| O Antigens | 2 | 2007 | 196 | 0.250 |
Why?
|
| APACHE | 2 | 2020 | 268 | 0.240 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 5892 | 0.240 |
Why?
|
| Staphylococcal Infections | 2 | 2011 | 1398 | 0.240 |
Why?
|
| Exotoxins | 4 | 2010 | 123 | 0.240 |
Why?
|
| Catheterization, Peripheral | 1 | 2008 | 347 | 0.240 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2006 | 347 | 0.240 |
Why?
|
| Yersinia pestis | 1 | 2004 | 33 | 0.230 |
Why?
|
| Quality of Health Care | 1 | 2019 | 4339 | 0.230 |
Why?
|
| Electronic Health Records | 1 | 2021 | 4879 | 0.220 |
Why?
|
| Endothelium | 6 | 2008 | 768 | 0.220 |
Why?
|
| Epithelium | 13 | 2006 | 1607 | 0.220 |
Why?
|
| Integrins | 1 | 2008 | 843 | 0.220 |
Why?
|
| Virulence Factors | 5 | 2010 | 502 | 0.210 |
Why?
|
| Mortality | 1 | 2014 | 2914 | 0.210 |
Why?
|
| Specimen Handling | 1 | 2007 | 708 | 0.210 |
Why?
|
| Acid-Base Equilibrium | 1 | 2023 | 180 | 0.210 |
Why?
|
| Body Fluids | 6 | 1996 | 322 | 0.200 |
Why?
|
| Bacterial Infections | 2 | 2008 | 1397 | 0.200 |
Why?
|
| Self-Help Groups | 1 | 2023 | 194 | 0.200 |
Why?
|
| Polymorphism, Genetic | 2 | 2010 | 4251 | 0.200 |
Why?
|
| Staphylococcus aureus | 1 | 2010 | 1430 | 0.190 |
Why?
|
| Length of Stay | 3 | 2014 | 6526 | 0.190 |
Why?
|
| School Admission Criteria | 2 | 2013 | 107 | 0.190 |
Why?
|
| Capillary Permeability | 7 | 2008 | 773 | 0.190 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2018 | 507 | 0.190 |
Why?
|
| Bronchoscopy | 1 | 2007 | 914 | 0.190 |
Why?
|
| Animals | 75 | 2011 | 169335 | 0.190 |
Why?
|
| Biomedical Research | 2 | 2014 | 3463 | 0.190 |
Why?
|
| Hospital Mortality | 3 | 2018 | 5369 | 0.180 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2020 | 641 | 0.180 |
Why?
|
| Anesthesia, Local | 1 | 2023 | 279 | 0.180 |
Why?
|
| Hospital Units | 1 | 2021 | 142 | 0.180 |
Why?
|
| Personnel Selection | 2 | 2013 | 201 | 0.180 |
Why?
|
| Leukocidins | 2 | 2010 | 18 | 0.180 |
Why?
|
| Aspirin | 1 | 2012 | 3135 | 0.170 |
Why?
|
| Delirium | 2 | 2022 | 1696 | 0.170 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2004 | 587 | 0.170 |
Why?
|
| Vital Signs | 1 | 2021 | 146 | 0.170 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2012 | 2763 | 0.170 |
Why?
|
| Antigens, Neoplasm | 1 | 2008 | 2001 | 0.170 |
Why?
|
| Hemorrhage | 1 | 2012 | 3466 | 0.170 |
Why?
|
| Liposomes | 5 | 2008 | 793 | 0.170 |
Why?
|
| Positive-Pressure Respiration | 2 | 2003 | 713 | 0.170 |
Why?
|
| Chemokines, CXC | 2 | 2003 | 420 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 12253 | 0.160 |
Why?
|
| Pentoxifylline | 2 | 1999 | 53 | 0.160 |
Why?
|
| Hydrochloric Acid | 2 | 1998 | 76 | 0.160 |
Why?
|
| Bacteremia | 4 | 2008 | 985 | 0.160 |
Why?
|
| Neutrophils | 9 | 2011 | 3785 | 0.150 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2001 | 453 | 0.150 |
Why?
|
| Hemostasis, Surgical | 1 | 2018 | 127 | 0.150 |
Why?
|
| Quorum Sensing | 2 | 2010 | 137 | 0.150 |
Why?
|
| Chemotaxis, Leukocyte | 3 | 1996 | 660 | 0.150 |
Why?
|
| Drug Therapy, Combination | 2 | 1999 | 6320 | 0.150 |
Why?
|
| Physicians | 1 | 2016 | 4607 | 0.150 |
Why?
|
| Periodicals as Topic | 1 | 2008 | 1470 | 0.140 |
Why?
|
| Male | 67 | 2022 | 365203 | 0.140 |
Why?
|
| Cell Line | 14 | 2010 | 15604 | 0.140 |
Why?
|
| Endopeptidases | 2 | 1998 | 764 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 5 | 2010 | 6086 | 0.140 |
Why?
|
| Lipopolysaccharides | 3 | 2011 | 2222 | 0.140 |
Why?
|
| Extracellular Space | 4 | 1993 | 565 | 0.140 |
Why?
|
| Heart Function Tests | 1 | 1998 | 317 | 0.140 |
Why?
|
| Wounds and Injuries | 4 | 2010 | 2517 | 0.140 |
Why?
|
| Body Water | 2 | 1996 | 340 | 0.140 |
Why?
|
| Patients | 1 | 2023 | 908 | 0.140 |
Why?
|
| Postoperative Complications | 8 | 2022 | 15889 | 0.140 |
Why?
|
| Blood Loss, Surgical | 2 | 2018 | 643 | 0.140 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 1998 | 353 | 0.130 |
Why?
|
| Interleukin-10 | 3 | 2002 | 1183 | 0.130 |
Why?
|
| Gene Expression Regulation, Bacterial | 4 | 2010 | 1137 | 0.130 |
Why?
|
| Immunization, Passive | 4 | 2009 | 619 | 0.130 |
Why?
|
| Epithelial Cells | 5 | 2008 | 3702 | 0.130 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2021 | 749 | 0.130 |
Why?
|
| Platelet Count | 1 | 2018 | 787 | 0.130 |
Why?
|
| Clodronic Acid | 2 | 2008 | 60 | 0.130 |
Why?
|
| DNA, Recombinant | 1 | 1996 | 455 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 11 | 2009 | 6232 | 0.130 |
Why?
|
| Platelet Transfusion | 1 | 2018 | 301 | 0.130 |
Why?
|
| Feasibility Studies | 2 | 2021 | 5323 | 0.120 |
Why?
|
| Cystic Fibrosis | 5 | 2011 | 1295 | 0.120 |
Why?
|
| Plant Lectins | 1 | 1995 | 103 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 12 | 2003 | 8144 | 0.120 |
Why?
|
| Muscle, Skeletal | 1 | 2010 | 4978 | 0.120 |
Why?
|
| History, 20th Century | 2 | 2014 | 2771 | 0.120 |
Why?
|
| Lysophospholipase | 2 | 2004 | 66 | 0.120 |
Why?
|
| Rats | 15 | 2008 | 23786 | 0.120 |
Why?
|
| Proteomics | 1 | 2008 | 3914 | 0.120 |
Why?
|
| Genomic Islands | 1 | 2014 | 52 | 0.110 |
Why?
|
| Female | 48 | 2023 | 397515 | 0.110 |
Why?
|
| Random Amplified Polymorphic DNA Technique | 2 | 2011 | 20 | 0.110 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2003 | 1658 | 0.110 |
Why?
|
| Endoscopy | 1 | 2023 | 1862 | 0.110 |
Why?
|
| DNA, Bacterial | 5 | 2014 | 1478 | 0.110 |
Why?
|
| Pleurisy | 1 | 1993 | 54 | 0.110 |
Why?
|
| Treatment Outcome | 9 | 2021 | 65480 | 0.110 |
Why?
|
| Empyema, Pleural | 1 | 1993 | 62 | 0.110 |
Why?
|
| Permeability | 5 | 1996 | 726 | 0.110 |
Why?
|
| Anesthetics, Inhalation | 1 | 1998 | 573 | 0.110 |
Why?
|
| Monokines | 3 | 2006 | 71 | 0.100 |
Why?
|
| Mothers | 1 | 2023 | 2209 | 0.100 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2020 | 997 | 0.100 |
Why?
|
| Gene Transfer Techniques | 1 | 1997 | 1209 | 0.100 |
Why?
|
| Cytotoxins | 2 | 2007 | 154 | 0.100 |
Why?
|
| Phagocytosis | 3 | 2008 | 1530 | 0.100 |
Why?
|
| Pulmonary Gas Exchange | 4 | 2006 | 389 | 0.100 |
Why?
|
| Anticoagulants | 1 | 2008 | 4850 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 7 | 2011 | 3813 | 0.100 |
Why?
|
| Histamine Release | 1 | 2011 | 134 | 0.100 |
Why?
|
| Video Recording | 1 | 2017 | 976 | 0.100 |
Why?
|
| Blood Coagulation | 2 | 2008 | 1161 | 0.100 |
Why?
|
| Language | 1 | 2021 | 1559 | 0.100 |
Why?
|
| Culture Techniques | 1 | 2012 | 530 | 0.090 |
Why?
|
| Quality Indicators, Health Care | 1 | 2021 | 1812 | 0.090 |
Why?
|
| Faculty | 1 | 2014 | 383 | 0.090 |
Why?
|
| Nasal Lavage Fluid | 1 | 2010 | 17 | 0.090 |
Why?
|
| Pulmonary Fibrosis | 2 | 2008 | 506 | 0.090 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2022 | 1483 | 0.090 |
Why?
|
| Evidence-Based Medicine | 2 | 2018 | 3709 | 0.090 |
Why?
|
| Surgical Wound Infection | 1 | 2020 | 1547 | 0.090 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 15471 | 0.090 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 2 | 2011 | 49 | 0.090 |
Why?
|
| Cell Membrane Permeability | 4 | 1998 | 573 | 0.090 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 1992 | 238 | 0.090 |
Why?
|
| Sepsis | 4 | 2002 | 2610 | 0.090 |
Why?
|
| Cohort Studies | 8 | 2020 | 41808 | 0.090 |
Why?
|
| Administration, Inhalation | 3 | 2006 | 1169 | 0.090 |
Why?
|
| Reactive Nitrogen Species | 1 | 2010 | 35 | 0.090 |
Why?
|
| Respiratory Function Tests | 1 | 2015 | 1694 | 0.090 |
Why?
|
| Mice | 24 | 2011 | 82072 | 0.090 |
Why?
|
| General Surgery | 1 | 2021 | 1722 | 0.080 |
Why?
|
| Histamine | 1 | 2011 | 496 | 0.080 |
Why?
|
| Aged | 24 | 2022 | 171786 | 0.080 |
Why?
|
| Bacteria | 3 | 2010 | 2216 | 0.080 |
Why?
|
| Pseudomonas Vaccines | 1 | 2009 | 24 | 0.080 |
Why?
|
| Lung Injury | 3 | 2008 | 433 | 0.080 |
Why?
|
| Immunoglobulin G | 5 | 2010 | 4568 | 0.080 |
Why?
|
| Aztreonam | 2 | 1999 | 10 | 0.080 |
Why?
|
| Biofilms | 2 | 2011 | 634 | 0.080 |
Why?
|
| Monobactams | 2 | 1999 | 16 | 0.080 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2010 | 301 | 0.080 |
Why?
|
| Protein C | 1 | 2009 | 134 | 0.080 |
Why?
|
| Surgical Procedures, Operative | 2 | 1998 | 1941 | 0.080 |
Why?
|
| Respiratory Mechanics | 2 | 1992 | 722 | 0.080 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2009 | 57 | 0.080 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2010 | 148 | 0.080 |
Why?
|
| Endotoxins | 1 | 1991 | 520 | 0.080 |
Why?
|
| Consumer Advocacy | 1 | 2009 | 83 | 0.080 |
Why?
|
| Cytokines | 4 | 2008 | 7453 | 0.080 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2009 | 150 | 0.080 |
Why?
|
| Gene Rearrangement | 1 | 2014 | 1148 | 0.080 |
Why?
|
| Endothelium, Vascular | 4 | 1998 | 4428 | 0.080 |
Why?
|
| Cilastatin | 2 | 1999 | 12 | 0.080 |
Why?
|
| Receptors, Vitronectin | 1 | 2008 | 48 | 0.080 |
Why?
|
| France | 1 | 2010 | 497 | 0.080 |
Why?
|
| Disease Models, Animal | 7 | 2008 | 18354 | 0.080 |
Why?
|
| Respiratory System | 1 | 2012 | 565 | 0.080 |
Why?
|
| Imipenem | 2 | 1999 | 38 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2004 | 4756 | 0.080 |
Why?
|
| Microbial Sensitivity Tests | 4 | 2011 | 1967 | 0.080 |
Why?
|
| Equipment Failure | 1 | 2011 | 585 | 0.080 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2010 | 247 | 0.080 |
Why?
|
| Prospective Studies | 14 | 2018 | 54962 | 0.080 |
Why?
|
| Chemokine CXCL2 | 4 | 2006 | 105 | 0.080 |
Why?
|
| Hemodynamics | 9 | 2001 | 4199 | 0.080 |
Why?
|
| Group Processes | 1 | 2009 | 228 | 0.070 |
Why?
|
| Drug Resistance, Microbial | 1 | 2011 | 830 | 0.070 |
Why?
|
| Recombinant Proteins | 4 | 2008 | 6512 | 0.070 |
Why?
|
| Risk Factors | 12 | 2020 | 74976 | 0.070 |
Why?
|
| Survival Rate | 4 | 2008 | 12873 | 0.070 |
Why?
|
| Opportunistic Infections | 1 | 2010 | 375 | 0.070 |
Why?
|
| Antibodies, Blocking | 1 | 2008 | 250 | 0.070 |
Why?
|
| Coronary Artery Bypass | 3 | 1992 | 2194 | 0.070 |
Why?
|
| Airway Obstruction | 2 | 1994 | 672 | 0.070 |
Why?
|
| Gene Deletion | 2 | 2008 | 2674 | 0.070 |
Why?
|
| Abdomen | 2 | 1993 | 1137 | 0.070 |
Why?
|
| Fimbriae, Bacterial | 2 | 2006 | 138 | 0.070 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2008 | 237 | 0.070 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2008 | 246 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2006 | 4356 | 0.070 |
Why?
|
| Academies and Institutes | 1 | 2009 | 326 | 0.070 |
Why?
|
| Proteins | 10 | 1997 | 6011 | 0.070 |
Why?
|
| DNA Transposable Elements | 2 | 2009 | 764 | 0.070 |
Why?
|
| Aerosols | 2 | 2002 | 636 | 0.070 |
Why?
|
| Inspiratory Capacity | 1 | 2006 | 35 | 0.070 |
Why?
|
| Quinolones | 1 | 2010 | 389 | 0.070 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2008 | 306 | 0.070 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2010 | 350 | 0.070 |
Why?
|
| Hospitals, University | 1 | 2008 | 570 | 0.070 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2011 | 1027 | 0.070 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2006 | 32 | 0.070 |
Why?
|
| Middle Aged | 22 | 2020 | 223737 | 0.070 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 5544 | 0.070 |
Why?
|
| DNA Primers | 3 | 2010 | 2827 | 0.070 |
Why?
|
| Smoke Inhalation Injury | 1 | 2006 | 47 | 0.070 |
Why?
|
| Quality Improvement | 1 | 2021 | 3860 | 0.070 |
Why?
|
| Pneumonia, Aspiration | 2 | 1997 | 145 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2008 | 1731 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 4 | 2014 | 4785 | 0.060 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2009 | 633 | 0.060 |
Why?
|
| Poly(ADP-ribose) Polymerases | 3 | 1997 | 428 | 0.060 |
Why?
|
| Fluoroquinolones | 1 | 2008 | 309 | 0.060 |
Why?
|
| Genetic Variation | 2 | 2014 | 6611 | 0.060 |
Why?
|
| Acute Disease | 5 | 2004 | 7245 | 0.060 |
Why?
|
| Japan | 1 | 2010 | 1418 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 1998 | 4939 | 0.060 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2006 | 139 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2004 | 2488 | 0.060 |
Why?
|
| Sodium | 1 | 1990 | 1597 | 0.060 |
Why?
|
| Multicenter Studies as Topic | 1 | 2010 | 1737 | 0.060 |
Why?
|
| Albuterol | 1 | 2006 | 211 | 0.060 |
Why?
|
| Patient Discharge | 1 | 2018 | 3491 | 0.060 |
Why?
|
| United States | 5 | 2022 | 73186 | 0.060 |
Why?
|
| Blood-Air Barrier | 3 | 1997 | 24 | 0.060 |
Why?
|
| DNA | 2 | 2002 | 7214 | 0.060 |
Why?
|
| Heart Failure | 5 | 2022 | 11879 | 0.060 |
Why?
|
| Immunoblotting | 3 | 2004 | 1647 | 0.060 |
Why?
|
| Receptors, Immunologic | 2 | 2011 | 1418 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2008 | 11932 | 0.060 |
Why?
|
| Time Factors | 4 | 2019 | 40261 | 0.060 |
Why?
|
| Chromatography, Liquid | 1 | 2008 | 997 | 0.060 |
Why?
|
| History, 21st Century | 1 | 2010 | 1575 | 0.060 |
Why?
|
| Vascular Surgical Procedures | 1 | 1993 | 1515 | 0.060 |
Why?
|
| Hemostasis | 1 | 2007 | 468 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2010 | 13021 | 0.060 |
Why?
|
| Protein Transport | 1 | 2010 | 1956 | 0.060 |
Why?
|
| Pandemics | 2 | 2022 | 8749 | 0.060 |
Why?
|
| Blood Pressure | 5 | 2008 | 8544 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2023 | 24333 | 0.060 |
Why?
|
| Hypertension, Pulmonary | 2 | 1987 | 1601 | 0.060 |
Why?
|
| Oxidative Stress | 2 | 2010 | 3139 | 0.060 |
Why?
|
| Lymphatic System | 4 | 1988 | 251 | 0.060 |
Why?
|
| Universities | 1 | 2009 | 1005 | 0.060 |
Why?
|
| Bioterrorism | 1 | 2004 | 144 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2003 | 16053 | 0.060 |
Why?
|
| Microscopy, Electron | 5 | 1995 | 2560 | 0.060 |
Why?
|
| Nasal Cavity | 1 | 2006 | 311 | 0.060 |
Why?
|
| Mentors | 1 | 2009 | 672 | 0.050 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2003 | 58 | 0.050 |
Why?
|
| Coronary Disease | 1 | 1998 | 5919 | 0.050 |
Why?
|
| Dogs | 6 | 1997 | 3845 | 0.050 |
Why?
|
| Lymph | 5 | 1990 | 78 | 0.050 |
Why?
|
| Respiratory Tract Diseases | 1 | 1989 | 744 | 0.050 |
Why?
|
| Mouth | 1 | 2006 | 383 | 0.050 |
Why?
|
| Molecular Sequence Data | 7 | 2007 | 17629 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3118 | 0.050 |
Why?
|
| Bacterial Typing Techniques | 1 | 2003 | 263 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3241 | 0.050 |
Why?
|
| Mice, Inbred C3H | 1 | 2004 | 915 | 0.050 |
Why?
|
| Ecosystem | 1 | 2007 | 494 | 0.050 |
Why?
|
| Serotyping | 1 | 2003 | 331 | 0.050 |
Why?
|
| Pulmonary Wedge Pressure | 4 | 1988 | 276 | 0.050 |
Why?
|
| Spleen | 1 | 2008 | 2294 | 0.050 |
Why?
|
| Internship and Residency | 2 | 2013 | 5956 | 0.050 |
Why?
|
| Thorax | 1 | 1985 | 557 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2008 | 1197 | 0.050 |
Why?
|
| Carbohydrate Metabolism | 1 | 2003 | 262 | 0.050 |
Why?
|
| Host-Pathogen Interactions | 1 | 2010 | 1469 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2010 | 2149 | 0.050 |
Why?
|
| Mixed Connective Tissue Disease | 1 | 1981 | 32 | 0.050 |
Why?
|
| Drug Combinations | 2 | 1999 | 2089 | 0.050 |
Why?
|
| Phenotype | 7 | 2008 | 16731 | 0.050 |
Why?
|
| Boston | 1 | 2014 | 9377 | 0.050 |
Why?
|
| Membrane Glycoproteins | 3 | 2011 | 3713 | 0.050 |
Why?
|
| Drug Delivery Systems | 2 | 2011 | 2238 | 0.050 |
Why?
|
| Publishing | 1 | 2008 | 837 | 0.050 |
Why?
|
| Reperfusion Injury | 1 | 2008 | 1036 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 2002 | 9264 | 0.050 |
Why?
|
| Amino Acid Sequence | 5 | 2004 | 13427 | 0.050 |
Why?
|
| Chemokine CXCL1 | 2 | 2003 | 102 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2010 | 1048 | 0.050 |
Why?
|
| Carbohydrates | 1 | 2003 | 389 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 8760 | 0.040 |
Why?
|
| Base Sequence | 4 | 2010 | 12430 | 0.040 |
Why?
|
| Adult | 19 | 2020 | 223851 | 0.040 |
Why?
|
| Preoperative Care | 2 | 2001 | 2258 | 0.040 |
Why?
|
| Anti-Infective Agents | 1 | 2008 | 984 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 2004 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2010 | 3782 | 0.040 |
Why?
|
| Biological Assay | 1 | 2003 | 628 | 0.040 |
Why?
|
| Emergency Treatment | 1 | 2003 | 497 | 0.040 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2008 | 1356 | 0.040 |
Why?
|
| Statistics, Nonparametric | 2 | 2018 | 2862 | 0.040 |
Why?
|
| Equipment Design | 1 | 2007 | 3530 | 0.040 |
Why?
|
| Blood Proteins | 2 | 1984 | 1191 | 0.040 |
Why?
|
| Hyperglycemia | 1 | 2008 | 1389 | 0.040 |
Why?
|
| Escherichia coli | 1 | 1991 | 4213 | 0.040 |
Why?
|
| Nitric Oxide | 2 | 1998 | 2149 | 0.040 |
Why?
|
| Homoserine | 1 | 1998 | 12 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2011 | 14484 | 0.040 |
Why?
|
| Cathelicidins | 1 | 1998 | 81 | 0.040 |
Why?
|
| Nitrobenzenes | 1 | 1998 | 64 | 0.040 |
Why?
|
| 4-Butyrolactone | 1 | 1998 | 60 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2010 | 3968 | 0.040 |
Why?
|
| Morbidity | 1 | 2003 | 1757 | 0.040 |
Why?
|
| Dimyristoylphosphatidylcholine | 1 | 1997 | 26 | 0.040 |
Why?
|
| Sulfonamides | 2 | 1998 | 1981 | 0.040 |
Why?
|
| Pulmonary Circulation | 4 | 1997 | 744 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2023 | 81903 | 0.040 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1997 | 221 | 0.040 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2003 | 1243 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 2011 | 220 | 0.040 |
Why?
|
| Leukocyte Count | 3 | 1997 | 1609 | 0.040 |
Why?
|
| Extravascular Lung Water | 2 | 1995 | 21 | 0.040 |
Why?
|
| Obesity | 1 | 2020 | 13091 | 0.040 |
Why?
|
| Phosphatidylethanolamines | 1 | 1997 | 131 | 0.040 |
Why?
|
| Lung Diseases, Obstructive | 2 | 1989 | 311 | 0.040 |
Why?
|
| Hydrostatic Pressure | 4 | 1996 | 99 | 0.040 |
Why?
|
| Chromosome Mapping | 2 | 2003 | 4625 | 0.040 |
Why?
|
| Macrophages | 3 | 2008 | 5801 | 0.040 |
Why?
|
| Anesthetics | 1 | 2003 | 525 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 1996 | 1553 | 0.040 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 1998 | 318 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2003 | 1445 | 0.030 |
Why?
|
| Leukocyte Elastase | 1 | 1997 | 114 | 0.030 |
Why?
|
| Inflammation Mediators | 2 | 2011 | 1890 | 0.030 |
Why?
|
| Albumins | 2 | 1991 | 577 | 0.030 |
Why?
|
| Receptors, Complement 3b | 1 | 1996 | 136 | 0.030 |
Why?
|
| Critical Illness | 1 | 2009 | 2754 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2003 | 3102 | 0.030 |
Why?
|
| Genes, Bacterial | 4 | 2005 | 1076 | 0.030 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 1998 | 361 | 0.030 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 1997 | 174 | 0.030 |
Why?
|
| Acids | 1 | 1996 | 125 | 0.030 |
Why?
|
| Absorption | 1 | 1996 | 244 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2001 | 904 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 1998 | 1169 | 0.030 |
Why?
|
| Iodine Radioisotopes | 2 | 1998 | 1034 | 0.030 |
Why?
|
| Chemotactic Factors | 1 | 1996 | 197 | 0.030 |
Why?
|
| Kidney | 3 | 2008 | 7058 | 0.030 |
Why?
|
| Concanavalin A | 1 | 1995 | 190 | 0.030 |
Why?
|
| Interleukin-8 | 2 | 1999 | 705 | 0.030 |
Why?
|
| Hyperoxia | 1 | 1997 | 261 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2010 | 3253 | 0.030 |
Why?
|
| Glycoconjugates | 1 | 1995 | 88 | 0.030 |
Why?
|
| Logistic Models | 3 | 2011 | 13318 | 0.030 |
Why?
|
| Immunization | 1 | 1999 | 1220 | 0.030 |
Why?
|
| Nitrogen Dioxide | 1 | 1997 | 534 | 0.030 |
Why?
|
| Piperacillin | 1 | 2014 | 37 | 0.030 |
Why?
|
| Species Specificity | 3 | 2011 | 2417 | 0.030 |
Why?
|
| Cells, Cultured | 6 | 2011 | 19023 | 0.030 |
Why?
|
| Liver | 2 | 2008 | 7578 | 0.030 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2014 | 142 | 0.030 |
Why?
|
| Penicillanic Acid | 1 | 2014 | 41 | 0.030 |
Why?
|
| Serum Albumin, Radio-Iodinated | 1 | 1993 | 37 | 0.030 |
Why?
|
| Respiratory Hypersensitivity | 1 | 1996 | 272 | 0.030 |
Why?
|
| Drug Interactions | 1 | 1998 | 1418 | 0.030 |
Why?
|
| Glycine | 1 | 1997 | 672 | 0.030 |
Why?
|
| Growth Substances | 1 | 1996 | 760 | 0.030 |
Why?
|
| Clindamycin | 1 | 2014 | 138 | 0.030 |
Why?
|
| Thrombosis | 1 | 2008 | 2956 | 0.030 |
Why?
|
| Molecular Typing | 1 | 2014 | 115 | 0.030 |
Why?
|
| Oxygen | 3 | 1999 | 4272 | 0.030 |
Why?
|
| Mutation | 5 | 2010 | 30266 | 0.030 |
Why?
|
| Catecholamines | 1 | 1994 | 389 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1998 | 1687 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2009 | 8055 | 0.030 |
Why?
|
| Burns | 1 | 2005 | 1901 | 0.030 |
Why?
|
| Phospholipases A | 2 | 2004 | 204 | 0.030 |
Why?
|
| Mediastinum | 2 | 1985 | 272 | 0.030 |
Why?
|
| Lectins | 1 | 1995 | 490 | 0.030 |
Why?
|
| Aged, 80 and over | 7 | 2014 | 59739 | 0.030 |
Why?
|
| Phylogeny | 2 | 2010 | 2843 | 0.030 |
Why?
|
| RNA, Messenger | 5 | 2003 | 12806 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2003 | 2682 | 0.030 |
Why?
|
| Pyocyanine | 1 | 2011 | 20 | 0.020 |
Why?
|
| Glycosylation | 1 | 1995 | 1101 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 1996 | 1157 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 1996 | 2231 | 0.020 |
Why?
|
| Asthma | 1 | 2010 | 6293 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 10765 | 0.020 |
Why?
|
| Pulmonary Atelectasis | 1 | 1992 | 160 | 0.020 |
Why?
|
| tau Proteins | 1 | 2022 | 2146 | 0.020 |
Why?
|
| Bacterial Vaccines | 1 | 1993 | 400 | 0.020 |
Why?
|
| Genetic Markers | 1 | 1997 | 2604 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 12095 | 0.020 |
Why?
|
| Plasmids | 1 | 1996 | 2269 | 0.020 |
Why?
|
| Clarithromycin | 1 | 2010 | 87 | 0.020 |
Why?
|
| Hypertension | 3 | 1987 | 8617 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 3810 | 0.020 |
Why?
|
| Biological Transport, Active | 1 | 1990 | 323 | 0.020 |
Why?
|
| Peroxidase | 3 | 1999 | 610 | 0.020 |
Why?
|
| Hydroxybutyrates | 1 | 2010 | 76 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2011 | 521 | 0.020 |
Why?
|
| Pancreatic Elastase | 1 | 2010 | 125 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2003 | 6413 | 0.020 |
Why?
|
| Hydrogen | 1 | 2010 | 171 | 0.020 |
Why?
|
| Sequence Alignment | 2 | 2004 | 2179 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1999 | 1811 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 14752 | 0.020 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2010 | 190 | 0.020 |
Why?
|
| Spirometry | 1 | 1992 | 929 | 0.020 |
Why?
|
| Thrombomodulin | 1 | 2009 | 107 | 0.020 |
Why?
|
| San Francisco | 1 | 2009 | 166 | 0.020 |
Why?
|
| Cell Survival | 2 | 1999 | 5793 | 0.020 |
Why?
|
| Genome, Bacterial | 1 | 2014 | 796 | 0.020 |
Why?
|
| Respiratory Paralysis | 1 | 1989 | 32 | 0.020 |
Why?
|
| Antibody Affinity | 1 | 2009 | 253 | 0.020 |
Why?
|
| Gene Expression | 2 | 2001 | 7603 | 0.020 |
Why?
|
| SRS-A | 1 | 1988 | 132 | 0.020 |
Why?
|
| Oleic Acids | 1 | 1988 | 71 | 0.020 |
Why?
|
| Oleic Acid | 1 | 1988 | 91 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 1992 | 1149 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 6856 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 2784 | 0.020 |
Why?
|
| Hydrothorax | 1 | 1988 | 20 | 0.020 |
Why?
|
| Infant | 3 | 2011 | 36556 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 1993 | 1831 | 0.020 |
Why?
|
| Esophagectomy | 1 | 1991 | 482 | 0.020 |
Why?
|
| Anesthesia, General | 4 | 1997 | 1189 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 2007 | 4168 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 1992 | 1528 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2011 | 582 | 0.020 |
Why?
|
| Goats | 2 | 1999 | 166 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2011 | 8748 | 0.020 |
Why?
|
| Leukotriene B4 | 1 | 1988 | 281 | 0.020 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2008 | 199 | 0.020 |
Why?
|
| Vaccines, Synthetic | 1 | 2009 | 622 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2008 | 1065 | 0.020 |
Why?
|
| Larynx | 1 | 1991 | 492 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2011 | 42683 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2011 | 1645 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 1993 | 1614 | 0.020 |
Why?
|
| Cardiac Output | 2 | 1986 | 838 | 0.020 |
Why?
|
| Phospholipids | 1 | 2010 | 787 | 0.020 |
Why?
|
| von Willebrand Factor | 1 | 1990 | 680 | 0.020 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 1988 | 239 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2008 | 1163 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2001 | 9384 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 1992 | 1321 | 0.020 |
Why?
|
| Vascular Resistance | 2 | 1986 | 939 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2018 | 10115 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 4 | 2011 | 22379 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 1988 | 610 | 0.020 |
Why?
|
| GTPase-Activating Proteins | 1 | 2008 | 469 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2010 | 1140 | 0.020 |
Why?
|
| Models, Biological | 2 | 2006 | 9499 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 20245 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2010 | 1194 | 0.010 |
Why?
|
| Octoxynol | 1 | 2004 | 76 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2010 | 1191 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2018 | 12467 | 0.010 |
Why?
|
| Neutropenia | 1 | 2009 | 893 | 0.010 |
Why?
|
| Mast Cells | 1 | 2011 | 1406 | 0.010 |
Why?
|
| Gene Library | 1 | 2007 | 1062 | 0.010 |
Why?
|
| Embolism, Air | 1 | 1984 | 110 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 1993 | 1241 | 0.010 |
Why?
|
| Adolescent | 5 | 2011 | 89244 | 0.010 |
Why?
|
| Monocytes | 1 | 1994 | 2603 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2022 | 22296 | 0.010 |
Why?
|
| Child | 4 | 2011 | 80960 | 0.010 |
Why?
|
| Prevalence | 1 | 2001 | 15879 | 0.010 |
Why?
|
| Trauma Centers | 1 | 2009 | 951 | 0.010 |
Why?
|
| Host-Parasite Interactions | 1 | 2006 | 303 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 12562 | 0.010 |
Why?
|
| Apoptosis | 2 | 2011 | 9527 | 0.010 |
Why?
|
| Sex Factors | 1 | 1998 | 10633 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2009 | 2227 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 11116 | 0.010 |
Why?
|
| Yersinia | 1 | 2003 | 9 | 0.010 |
Why?
|
| Transfection | 2 | 2002 | 5763 | 0.010 |
Why?
|
| Edetic Acid | 1 | 2004 | 278 | 0.010 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1989 | 1097 | 0.010 |
Why?
|
| Eukaryotic Cells | 1 | 2004 | 192 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 3438 | 0.010 |
Why?
|
| Prognosis | 4 | 2010 | 30046 | 0.010 |
Why?
|
| Pericardial Effusion | 1 | 1985 | 246 | 0.010 |
Why?
|
| Neutrophil Infiltration | 1 | 2006 | 395 | 0.010 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2003 | 99 | 0.010 |
Why?
|
| Glycerol | 1 | 2004 | 274 | 0.010 |
Why?
|
| Cardiovascular Diseases | 2 | 2003 | 15661 | 0.010 |
Why?
|
| Hospital Costs | 1 | 2009 | 959 | 0.010 |
Why?
|
| ROC Curve | 1 | 2011 | 3629 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2006 | 23653 | 0.010 |
Why?
|
| Cattle | 1 | 2008 | 3819 | 0.010 |
Why?
|
| Triglycerides | 1 | 2010 | 2464 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 1769 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2004 | 699 | 0.010 |
Why?
|
| Heart Atria | 2 | 1985 | 1361 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2001 | 26428 | 0.010 |
Why?
|
| Operon | 1 | 2003 | 371 | 0.010 |
Why?
|
| Dosage Forms | 1 | 2002 | 56 | 0.010 |
Why?
|
| Solvents | 1 | 2003 | 298 | 0.010 |
Why?
|
| Drug Storage | 1 | 2002 | 52 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2020 | 13055 | 0.010 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2009 | 862 | 0.010 |
Why?
|
| Virosomes | 1 | 2001 | 5 | 0.010 |
Why?
|
| Genetic Vectors | 2 | 2002 | 3412 | 0.010 |
Why?
|
| Up-Regulation | 2 | 2003 | 4148 | 0.010 |
Why?
|
| DNA, Circular | 1 | 2002 | 97 | 0.010 |
Why?
|
| Cation Exchange Resins | 1 | 2001 | 19 | 0.010 |
Why?
|
| Enzyme Stability | 1 | 2002 | 219 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2002 | 222 | 0.010 |
Why?
|
| Cytosol | 1 | 2004 | 886 | 0.010 |
Why?
|
| Drug Stability | 1 | 2002 | 292 | 0.010 |
Why?
|
| Heart Diseases | 1 | 1994 | 2819 | 0.010 |
Why?
|
| Epitope Mapping | 1 | 2002 | 300 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 1683 | 0.010 |
Why?
|
| Posture | 1 | 1985 | 957 | 0.010 |
Why?
|
| Lipase | 1 | 2003 | 321 | 0.010 |
Why?
|
| Peptides | 1 | 1993 | 4353 | 0.010 |
Why?
|
| Plant Proteins | 1 | 2003 | 376 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1997 | 7885 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 15951 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2009 | 2508 | 0.010 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2001 | 204 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 1998 | 7460 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 2002 | 642 | 0.010 |
Why?
|
| Complement Activation | 2 | 1996 | 447 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2009 | 2820 | 0.010 |
Why?
|
| Chromatography, Gel | 2 | 1993 | 637 | 0.010 |
Why?
|
| Proxy | 1 | 2001 | 150 | 0.010 |
Why?
|
| Pulmonary Artery | 2 | 1985 | 1945 | 0.010 |
Why?
|
| Point Mutation | 1 | 2004 | 1596 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2003 | 1524 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2009 | 1960 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2009 | 4032 | 0.010 |
Why?
|
| Immune Sera | 1 | 1999 | 605 | 0.010 |
Why?
|
| Cell Communication | 1 | 2006 | 1660 | 0.010 |
Why?
|
| Respiration | 1 | 1985 | 1668 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 2002 | 864 | 0.010 |
Why?
|
| Hospitalization | 1 | 2018 | 10847 | 0.010 |
Why?
|
| Treatment Refusal | 1 | 2001 | 433 | 0.010 |
Why?
|
| Peroxidases | 1 | 1998 | 135 | 0.010 |
Why?
|
| Intraoperative Complications | 2 | 1997 | 1176 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2004 | 2003 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 1998 | 455 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 14794 | 0.010 |
Why?
|
| Chemokines | 1 | 2002 | 963 | 0.010 |
Why?
|
| Genotype | 2 | 2005 | 13048 | 0.010 |
Why?
|
| Regulon | 1 | 1997 | 71 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1997 | 777 | 0.010 |
Why?
|
| Smoking | 1 | 1993 | 9094 | 0.010 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 1998 | 319 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2006 | 3232 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2010 | 6435 | 0.010 |
Why?
|
| Immunoglobulin Isotypes | 1 | 1996 | 158 | 0.010 |
Why?
|
| Curriculum | 1 | 2009 | 3782 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 1998 | 597 | 0.010 |
Why?
|
| Recurrence | 1 | 2008 | 8513 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2008 | 3592 | 0.010 |
Why?
|
| Perfusion | 2 | 1995 | 1402 | 0.010 |
Why?
|
| Interleukin-5 | 1 | 1996 | 267 | 0.010 |
Why?
|
| Dinoprostone | 1 | 1998 | 597 | 0.010 |
Why?
|
| Cushing Syndrome | 1 | 1977 | 241 | 0.010 |
Why?
|
| Solubility | 1 | 1996 | 1087 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 3744 | 0.010 |
Why?
|
| Amiloride | 1 | 1994 | 116 | 0.010 |
Why?
|
| Biological Transport | 1 | 1999 | 2085 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1977 | 573 | 0.010 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 1994 | 87 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 6131 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 1994 | 363 | 0.010 |
Why?
|
| Ovalbumin | 1 | 1996 | 677 | 0.010 |
Why?
|
| Pulmonary Ventilation | 1 | 1996 | 375 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1995 | 412 | 0.010 |
Why?
|
| beta-Thromboglobulin | 1 | 1993 | 20 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1994 | 243 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 1933 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1996 | 629 | 0.010 |
Why?
|
| Altitude Sickness | 1 | 1994 | 93 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 1985 | 3473 | 0.010 |
Why?
|
| Cell Polarity | 1 | 1997 | 639 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 3726 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 1 | 1994 | 326 | 0.010 |
Why?
|
| Counseling | 1 | 2001 | 1554 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1997 | 1229 | 0.010 |
Why?
|
| Propranolol | 1 | 1994 | 493 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1993 | 862 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1996 | 1890 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1994 | 867 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1985 | 6002 | 0.010 |
Why?
|
| Stroke Volume | 1 | 1986 | 5622 | 0.010 |
Why?
|
| Culture Media | 1 | 1994 | 898 | 0.010 |
Why?
|
| Blood Vessels | 1 | 1997 | 1110 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2001 | 2339 | 0.010 |
Why?
|
| Epinephrine | 1 | 1994 | 794 | 0.010 |
Why?
|
| Eosinophils | 1 | 1996 | 953 | 0.010 |
Why?
|
| Calcium | 1 | 2004 | 5792 | 0.010 |
Why?
|
| Protein Binding | 1 | 2003 | 9344 | 0.010 |
Why?
|
| E-Selectin | 1 | 1993 | 578 | 0.010 |
Why?
|
| Mice, SCID | 1 | 1996 | 2631 | 0.010 |
Why?
|
| Histological Techniques | 1 | 1991 | 194 | 0.010 |
Why?
|
| Microvilli | 1 | 1991 | 235 | 0.010 |
Why?
|
| Lipids | 1 | 2001 | 3345 | 0.010 |
Why?
|
| Biopsy | 1 | 1981 | 6805 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1993 | 1536 | 0.010 |
Why?
|
| Lung Volume Measurements | 1 | 1990 | 381 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1993 | 1251 | 0.000 |
Why?
|
| Protein Precursors | 1 | 1993 | 1135 | 0.000 |
Why?
|
| Mice, Transgenic | 1 | 2001 | 9565 | 0.000 |
Why?
|
| Central Venous Pressure | 1 | 1988 | 80 | 0.000 |
Why?
|
| Exudates and Transudates | 1 | 1988 | 175 | 0.000 |
Why?
|
| Trans-Activators | 1 | 1997 | 2858 | 0.000 |
Why?
|
| Intestines | 1 | 1996 | 1911 | 0.000 |
Why?
|
| Interferon-gamma | 1 | 1996 | 3163 | 0.000 |
Why?
|
| Hydrolysis | 1 | 1988 | 646 | 0.000 |
Why?
|
| Heart Valve Diseases | 1 | 1994 | 1030 | 0.000 |
Why?
|
| Vaccination | 1 | 1999 | 3438 | 0.000 |
Why?
|
| Plasmapheresis | 1 | 1987 | 206 | 0.000 |
Why?
|
| Autoradiography | 1 | 1987 | 728 | 0.000 |
Why?
|
| Brain Diseases | 1 | 1994 | 1558 | 0.000 |
Why?
|
| Inflammation | 1 | 2004 | 10868 | 0.000 |
Why?
|
| Syndrome | 1 | 1990 | 3274 | 0.000 |
Why?
|
| Young Adult | 1 | 2011 | 60131 | 0.000 |
Why?
|
| Venous Pressure | 1 | 1983 | 55 | 0.000 |
Why?
|
| Cell Movement | 1 | 1996 | 5216 | 0.000 |
Why?
|
| Myocardium | 1 | 1996 | 4790 | 0.000 |
Why?
|
| Phrenic Nerve | 1 | 1983 | 81 | 0.000 |
Why?
|
| Hepatic Veins | 1 | 1983 | 112 | 0.000 |
Why?
|
| Cautery | 1 | 1983 | 73 | 0.000 |
Why?
|
| Insulin | 1 | 1977 | 6610 | 0.000 |
Why?
|
| Capillaries | 1 | 1984 | 756 | 0.000 |
Why?
|
| Radionuclide Imaging | 1 | 1985 | 1998 | 0.000 |
Why?
|
| Veins | 1 | 1985 | 769 | 0.000 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1982 | 945 | 0.000 |
Why?
|
| Arteries | 1 | 1985 | 1126 | 0.000 |
Why?
|
| DNA-Binding Proteins | 1 | 1997 | 9618 | 0.000 |
Why?
|
| Drainage | 1 | 1985 | 1184 | 0.000 |
Why?
|
| Esophagus | 1 | 1985 | 1043 | 0.000 |
Why?
|
| Kinetics | 1 | 1987 | 6332 | 0.000 |
Why?
|
| Microcirculation | 1 | 1984 | 1281 | 0.000 |
Why?
|
| Electric Stimulation | 1 | 1983 | 1742 | 0.000 |
Why?
|
| Radiography | 1 | 1988 | 6991 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1984 | 2614 | 0.000 |
Why?
|
| Pneumonectomy | 1 | 1983 | 1159 | 0.000 |
Why?
|
| Blood Platelets | 1 | 1986 | 2479 | 0.000 |
Why?
|
| Heart | 1 | 1988 | 4447 | 0.000 |
Why?
|
| Adrenalectomy | 1 | 1977 | 348 | 0.000 |
Why?
|
| Hypoglycemia | 1 | 1977 | 895 | 0.000 |
Why?
|
| Hydrocortisone | 1 | 1977 | 1841 | 0.000 |
Why?
|
| Pituitary Neoplasms | 1 | 1977 | 1326 | 0.000 |
Why?
|
| Myocardial Infarction | 1 | 1986 | 11521 | 0.000 |
Why?
|